HLB THERAPEUTICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,660 KRW | -2.51% |
|
-3.95% | +165.91% |
| Sales 2022 | 48.13B 34.99M 2.92B | Sales 2023 | 53.75B 39.08M 3.26B | Capitalization | 331B 241M 20.07B |
|---|---|---|---|---|---|
| Net income 2022 | -11.35B -8.25M -688M | Net income 2023 | -2.3B -1.67M -139M | EV / Sales 2022 | 7.34 x |
| Net cash position 2022 | 11.88B 8.64M 720M | Net cash position 2023 | 22.33B 16.23M 1.35B | EV / Sales 2023 | 5.75 x |
| P/E ratio 2022 |
-30.6
x | P/E ratio 2023 |
-136
x | Employees | 91 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 86.01% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.51% | ||
| 1 week | -3.95% | ||
| Current month | -13.76% | ||
| 1 month | -20.14% | ||
| 3 months | +117.54% | ||
| 6 months | +253.90% | ||
| Current year | +165.91% |
1 week
11 000.00
13 090.00
1 month
11 000.0017 700.00
Current year
3 750.0017 700.00
1 year
2 840.5817 700.00
3 years
2 840.5817 700.00
5 years
2 840.5817 700.00
10 years
1 113.2126 558.38
| Managers | Title | Age | Since |
|---|---|---|---|
Ki-Hong An
CEO | Chief Executive Officer | 57 | - |
Yeok-Dong Kim
AUD | Comptroller/Controller/Auditor | 64 | 01/21/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yang-Gon Jin
BRD | Director/Board Member | 58 | - |
Jong-Won Kim
BRD | Director/Board Member | 61 | - |
Chang-Yoon Lim
BRD | Director/Board Member | 58 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 11,660 | -2.51% | 1,972,592 |
| 25/24/25 | 11,960 | -2.92% | 1,307,484 |
| 24/24/24 | 12,320 | -0.88% | 1,243,234 |
| 23/24/23 | 12,430 | +1.14% | 1,463,193 |
| 22/24/22 | 12,290 | +1.24% | 2,550,065 |
End-of-day quote Korea S.E., April 26, 2024
More quotes
HLB Therapeutics Co Ltd, formerly G-treeBNT Co Ltd, is a Korea-based company engaged in the research and development of optimized multimedia software for various digital appliances including cellular phones. Along with its affiliates, the Company operates solution business segment, which provides embedded graphic user interface (GUI) software solutions as well as wired and wireless integration multimedia platform solutions. Its embedded GUI products include FXUI-two-dimensional (2D), FXUI-three-dimensional (3D) and FX Studio, which are used for cellular phones and embedded equipment. Its wired and wireless integration multimedia platform products include FX-Flash and others, which are used for cellular phones and other mobile devices; electronic components manufacturing business segment, which provides transformers, pumps, motors and others, as well as educational and bio pharmaceutical business segments.
Sector
Pharmaceuticals
Calendar
10/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +165.91% | 636M | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B |
- Stock Market
- Equities
- A115450 Stock
